Medical devices, healthcare technology and the business of care
510(k) clearance · K262341

b-ONE Mobio Total Knee System Revision Cemented Tibial Augments, Stem Extensions and Press-Fit Stem Extensions

B-One Ortho, Corp. · Decision date Sep 8, 2026

FDA DECISIONK262341

What did the FDA decide?

FDA records K262341 as a 510(k) premarket notification, with a decision dated Sep 8, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Sep 8, 2026

FDA source record

Regulatory record facts

Identifier
K262341
Regulatory pathway
510(k) premarket notification
Product code
JWH
Decision code
SESE
Decision date
Sep 8, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer.

Product code
JWH
FDA device class
2

FDA decision timeline

  1. K262341 received

    Application receipt date recorded by FDA.

  2. K262341 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JWH

Product / regulatory recordCompanyPathwayDecision dateSource
Suzhou Microport Orthorecon Co., Ltd.510(k) clearanceOct 29, 2026FDA
Medacta International SA510(k) clearanceSep 15, 2026FDA
The General Hospital Corporation, d/b/a Massachusetts510(k) clearanceSep 11, 2026FDA
Suzhou Microport Orthorecon Co., Ltd.510(k) clearanceSep 10, 2026FDA
Depuy Orthopaedics, Inc.510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

B-One Ortho, Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Cedar Knolls, NJ

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records